Rx Roundup: Quiz of the Week — April 12, 2024

Quiz
Article

Test your pharmacy news knowledge with our weekly quiz.

Did you get your fill of pharmacy news this week? Take the Rx Roundup quiz of the week and test your knowledge about the latest stories published by the Drug Topics team from April 8 to April 12.

Approximately how many children in the United States are currently living with asthma?


Recent Videos
Related Content
FDA Approves Acoramidis for ATTR-CM

FDA Approves Acoramidis for ATTR-CM

Lauren Biscaldi, MS, Managing Editor
November 25th 2024
Article

This approval marks the availability of the first near-complete stabilizer of transthyretin.

Over the Counter podcast

Episode 8: Stay in Sync with Innovations in Medication Decision Support

Drug Topics staff
August 6th 2020
Podcast

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

FDA Roundup: Rosacea Treatment, Proposal to Remove Oral Phenylephrine from OTC Products

FDA Roundup: Rosacea Treatment, Proposal to Remove Oral Phenylephrine from OTC Products

Killian Meara
November 8th 2024
Article

Check out these important FDA updates from the week of November 4.

Why Vaccination Uptake is Crucial During the Winter Season

Why Vaccination Uptake is Crucial During the Winter Season

Brian Nowosielski
November 6th 2024
Article

Ruth Carrico, PhD, DNP, APRN, sat down with Drug Topics to discuss the importance of COVID-19 and influenza vaccination.

Lumateperone Demonstrates Efficacy in Reducing Symptomatic Relapse Risk in Schizophrenia

Lumateperone Demonstrates Efficacy in Reducing Symptomatic Relapse Risk in Schizophrenia

Lauren Biscaldi, MS, Managing Editor
November 5th 2024
Article

The drug is also approved to treat schizophrenia and bipolar depression.

FDA Approves Journey Medical’s Emrosi for Rosacea

FDA Approves Journey Medical’s Emrosi for Rosacea

Lauren Massaro
November 5th 2024
Article

“Emrosi has potential to become the best-in-class oral medication to treat the condition,” said the CEO of Journey Medical.

© 2024 MJH Life Sciences

All rights reserved.